Hepatosplenic Alpha-Beta T-Cell Lymphoma: A Challenging Diagnostic Entity

IF 1.3 Q4 HEMATOLOGY Journal of hematology Pub Date : 2024-04-01 DOI:10.14740/jh1203
A. Gabra, Joanna Polanco, Shrija Thapa, Sumit Sawhney, Alexey Glazyrin
{"title":"Hepatosplenic Alpha-Beta T-Cell Lymphoma: A Challenging Diagnostic Entity","authors":"A. Gabra, Joanna Polanco, Shrija Thapa, Sumit Sawhney, Alexey Glazyrin","doi":"10.14740/jh1203","DOIUrl":null,"url":null,"abstract":"Hepatosplenic T-cell lymphoma (HSTCL) is rare and clinically very aggressive T-cell lymphoma. The majority of cases harbor γδ T-cell receptors (TCRs); however, in some even rarer cases, tumor cells harbor αβ TCR. Recent studies suggest that αβ cases may have distinct morphological characteristics and demonstrate an even more aggressive course. In this case report, we demonstrated that in line with previous findings, αβ case of HSTCL had hemolytic presentation, demonstrated a very aggressive clinical course, and was unrelated to immunosuppression. Morphologically, tumor cells demonstrated diffuse growth pattern, blastoid morphology, and were CD8+ positive on the background of CD4+ small to medium reactive T cells. Additionally, the liver tumor cells demonstrated periportal localization, and in bone marrow, evidence of emperipolesis was noted. The latter finding may significantly contribute to pancytopenia characteristic, all types of HSTCL. Those unusual morphologic and clinical characteristics make diagnosis of this rare subtype of rare disease very challenging. More case analysis is required to establish whether αβ/γδ HSTCL are prognostically or morphologically significantly distinct entities.","PeriodicalId":15964,"journal":{"name":"Journal of hematology","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of hematology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14740/jh1203","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Hepatosplenic T-cell lymphoma (HSTCL) is rare and clinically very aggressive T-cell lymphoma. The majority of cases harbor γδ T-cell receptors (TCRs); however, in some even rarer cases, tumor cells harbor αβ TCR. Recent studies suggest that αβ cases may have distinct morphological characteristics and demonstrate an even more aggressive course. In this case report, we demonstrated that in line with previous findings, αβ case of HSTCL had hemolytic presentation, demonstrated a very aggressive clinical course, and was unrelated to immunosuppression. Morphologically, tumor cells demonstrated diffuse growth pattern, blastoid morphology, and were CD8+ positive on the background of CD4+ small to medium reactive T cells. Additionally, the liver tumor cells demonstrated periportal localization, and in bone marrow, evidence of emperipolesis was noted. The latter finding may significantly contribute to pancytopenia characteristic, all types of HSTCL. Those unusual morphologic and clinical characteristics make diagnosis of this rare subtype of rare disease very challenging. More case analysis is required to establish whether αβ/γδ HSTCL are prognostically or morphologically significantly distinct entities.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肝脾阿尔法-贝塔 T 细胞淋巴瘤:极具挑战性的诊断实体
肝脾T细胞淋巴瘤(HSTCL)是一种罕见的临床侵袭性T细胞淋巴瘤。大多数病例携带γδ T细胞受体(TCR);但在一些更罕见的病例中,肿瘤细胞携带αβ TCR。最近的研究表明,αβ病例可能具有不同的形态学特征,病程也更具侵袭性。在本病例报告中,我们发现αβ型HSTCL与之前的研究结果一致,具有溶血性表现,临床病程非常凶险,且与免疫抑制无关。从形态上看,肿瘤细胞呈弥漫性生长模式,呈泡状形态,在 CD4+ 中小型反应性 T 细胞的背景下呈 CD8+ 阳性。此外,肝脏肿瘤细胞表现为肝门周围定位,而在骨髓中,则发现了emperipolesis的证据。后者可能是所有类型 HSTCL 的全血细胞减少的重要原因。这些不寻常的形态学和临床特征使得诊断这种罕见亚型罕见病非常具有挑战性。需要对更多病例进行分析,以确定αβ/γδ HSTCL在预后或形态上是否是明显不同的实体。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of hematology
Journal of hematology HEMATOLOGY-
自引率
0.00%
发文量
29
期刊最新文献
Allogeneic Hematopoietic Stem Cell Transplantation After Solid Organ Transplantation in Patients With Hematologic Malignancies Managed With Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis. Controversies in the Management of Ischemic Cerebrovascular Accidents in Patients With Non-Promyelocytic Acute Myeloid Leukemia. Ferritin and Iron Levels Inversely Associated With Lymphoma Risk: A Mendelian Randomization Study. Freedom From Bleeds With Low-Dose Emicizumab Prophylaxis in Inhibitor-Positive Hemophilia A. Primary Refractory Discordant Diffuse Large B-Cell and Classical Hodgkin Lymphoma.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1